Click image to view original image
PharmaLegacy Laboratories (Shanghai) Co., Ltd is specialized in Business services,Medical service,Medical insurance since established in 10 years ago.So far,our company has established its branch companies in major cities throughout the country.Formed in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China as the center, the radiation sales system and service network.Details:Non-human primates model (NHP) have closer phylogenetic relationship to human and the disease targets in NHP models share high cross-reactivity to the human target specific biological molecules which do not react with rodent counterpart. PharmaLegacy has therefore developed and validated serials of NHP platforms, covering Inflammation/ Autoimmune Diseases, Bone/Orthopedics, Respiratory Disease, as well as Pharmacokinetics Profiling Assay to test pharmacological effects and mechanisms of candidate drugs especially for therapeutic monoclonal antibodies. Experiments involving non-human primates (NHPs) include toxicity testing for medical and non-medical substances; studies of infectious disease, such as HIV and hepatitis; neurological studies; behavior and cognition; reproduction; genetics; and xenotransplantation. Around 65,000 NHPs are used every year in the United States, and around 7,000 across the European Union. Most of the NHPs used are one of three species of macaques, accounting for 79% of all primates used in research in the UK, and 63% of all federally funded research grants for projects using primates in the U.S. Lesser numbers of marmosets, tamarins, spider monkeys, owl monkeys, vervet monkeys, squirrel monkeys, and baboons are used in the UK and the US. Great Apes have not been used in the UK since a Government policy ban in 1998.
